Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Court Urged to “Wind Up” Roundup MDL Proceedings, As Additional Lawsuits Continue to Move Toward Trial At a conference to discuss the status of the Roundup MDL, plaintiffs lawyers pushed for a global settlement or a plan to wrap up the pretrial proceedings September 8, 2022 Irvin Jackson Add Your Comments Following years of litigation and billions in settlements paid, plaintiffs lawyers are urging the federal judge appointed to preside over pretrial proceedings for all remaining Roundup lawsuits to start “wrapping up” the MDL, and return unresolved cases to U.S. District courts nationwide for trial. Bayer and its Monsanto subsidiary have faced more than 120,000 product liability lawsuits brought nationwide over the past seven years, each involving similar allegations consumers were not adequately warned about the risk of non-Hodgkins lymphoma (NHL) from Roundup. Given common questions of fact and law raised in complaints brought in various different U.S. District Courts, the U.S. Judicial Panel on Multidistrict Litigation established a Roundup MDL in 2016, centralizing the claims before U.S. District Judge Vince Chhabria in the Northern District of California for coordinated discovery and a series of early “bellwether” trials to help gauge how juries are likely to respond to certain evidence and testimony that was repeated throughout the lawsuits. Following a series of massive Roundup lawsuit payouts awarded during trials held throughout 2018 and 2019, Monsanto has engaged in an attempt to settle individual injury lawsuits with different law firms. However, with many plaintiffs rejecting the settlement offers, and new claims continuing to be filed as former users develop cancer, thousands of Roundup cases still are awaiting trial. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a statement (PDF) submitted in advance of a meeting with Judge Chhabria this week, plaintiffs indicate that Monsanto is still refusing to change the Roundup warning label and refusing to make meaningful attempts to settle remaining claims. Therefore, lawyers have ramped up the litigation, with a series of trials scheduled nationwide over the next ten months, and indicate that the time has come to “wind up” the Roundup MDL and start returning cases to U.S. District Courts nationwide if a global settlement can not be reached in the coming weeks. Upcoming Roundup Cancer Trials Plaintiffs indicate there are at least ten Roundup trials scheduled nationwide over the next ten months, none of which will be held in the federal court system. The upcoming trial dates include: 11/7/2022 – Langford v. Monsanto in California Superior Court (San Francisco) 11/29/2022 – Pied v. Monsanto in Hawaii Circuit Court (Hilo, Hawaii) 1/9/2023 – Griswold v. Monsanto in Missouri Circuit Court (St. Louis City) 1/23/2023 – Freiwald v. Monsanto in California Superior Court (San Francisco) 2/27/2023 – Chaplick v. Monsanto in Missouri Circuit Court (St. Louis County) 3/3/2023 – Weaver v. Monsanto in California Superior Court (San Diego) 4/3/2023 – Hedges v. Monsanto in Arizona Superior Court (Maricopa County) 4/24/2023 – Gordon v. Monsanto in Missouri Circuit Court (St. Louis County) 6/5/2023 – Lopez v. Monsanto in Florida Circuit Court (Wade County) 6/12/2023 – Moore v. Monsanto in Missouri County Circuit Court 6/26/2023 – Johnson v. Monsanto in California Superior Court (San Diego) Do You Have a Roundup Lawsuit? If you or a loved one were diagnosed with non-Hodgkins lymphoma (NHL) from Roundup, it may not be too late to pursue a settlement CONTACT A LAWYER In the federal MDL, Judge Chhabria has been presiding over a “wave” approach to prepare cases for trial, selecting dozens of individual claims from certain states for remand back to U.S. District Courts nationwide. However, plaintiffs indicated this is not a viable long-term plan, since it will result in the Roundup MDL remaining open indefinitely, as new lawsuits continue to be filed and constantly transferred from states which have already been addressed in previous waves. “Fundamentally, this MDL has accomplished nearly everything that should be expected of an MDL. Important common issues, such as preemption and general causation, have been vetted. Bellwether cases have been tried. Detailed orders concerning how to think about and adjudicate specific causation are available. Most cases have settled. Overall, this MDL has been a tremendous success,” according to the statement submitted by Plaintiffs Leadership attorneys. “It is, however, time to develop an exit plan – one that allows all the hard work that has been done to benefit cases as they are remanded back to their home jurisdictions for trial. In this vein, Plaintiffs propose a three-phase plan to wind up the MDL.” Proposed Plan to Wrap Up Roundup MDL In the first phase of the Roundup MDL wind up plan, Plaintiffs indicate that Judge Chhabria should give the parties 60 days to make one last attempt to forge a global Roundup settlement agreement that could resolve all claims nationwide. Over these next few weeks, they ask that the court suspend all deadlines. However, if Monsanto is unwilling to engage in such a plan, they recommend that the Court proceed to the second phase. Following a limited attempt to globally settle Roundup lawsuits, plaintiffs indicate that the MDL should officially end the “wave” program, and direct the Plaintiffs’ Leadership committee to maintain a “trial package” that is updated twice yearly, which would include exhibits, deposition transcripts, an outline for treating doctor depositions and all PowerPoints and exhibits used during prior trials. Each individual plaintiff would then be able to take this package back to the U.S. District Court where their claim originated for trial. Once Judge Chhabria is satisfied that a complete trial package exists, plaintiffs recommend the Court move into the third and final phase of the plan to wind up the Roundup MDL, remanding all remaining cases back to the appropriate federal district courts for trial. Following the full remand, plaintiffs propose the MDL for Roundup lawsuits be terminated and future lawsuits would be filed and remain in the U.S. District Courts where they originate. Monsanto Continues to Push For Status Quo In response to the plaintiffs’ proposal, Monsanto has requested that the Roundup MDL continue to prepare claims on a state-by-state basis, and push settlements through a court-ordered mediation process. Judge Chhabria previously appointed Special Master Ken Feinberg to preside over the Roundup settlement negotiations, requiring each plaintiff to participate in a mediation to obtain an offer to settle their case. Plaintiffs are not required to accept the settlement, and reports suggest the offers Monsanto makes at mediation fail to adequately compensate individuals who have developed NHL from Roundup. “[A]lmost 2 years later, it is evidence that the current MDL mediation program is not advancing case resolution in a meaningful way,” according to Plaintiffs’ Leadership. “As an initial matter, because Monsanto must ‘approve’ the mediator’s offers, the offers made within the settlement program appear to be woefully inadequate. Thus, a substantial number of MDL cases remain unresolved by the settlement program, and it is highly unlikely that these cases will be settled absent a global resolution or imminent trial setting.” Monsanto and Bayer are expected to face years of future litigation over Roundup, as unresolved claims work their way to trial and new lawsuit continue to be filed by individuals diagnosed with non-Hodgkins lymphoma who previously used the weed killer. To limit its future liability, Bayer announced last year that it will remove the active ingredient that causes cancer, glyphosate, from versions of the weed killer sold to U.S. residential customers by 2023. The products would still be sold under the Roundup label, but would use a different active ingredient, which has not been linked to a risk of non-Hodgkin’s lymphoma. However, glyphosate would still be used in products sold to agricultural businesses and farmers, and in product sold in other parts of the world, Bayer officials said. Tags: Bayer, Cancer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer More Roundup Lawsuit Stories Bayer’s Roundup Settlement Plan May Result in Monsanto Bankruptcy Filing: Report May 19, 2025 Georgia Lawmakers Agree To Shield Bayer From Roundup Cancer Lawsuits May 15, 2025 Roundup Exposure May Increase Infertility, Endometriosis Risks: Study May 1, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: today) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025) 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: yesterday) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 4 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: today) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: yesterday) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 4 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)